相关实验视频

Updated: Sep 16, 2025

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

9-cis-Retinoic酸改善了iPSC衍生的肝脏器官中的疾病建模

Mina Kazemzadeh Dastjerd¹, Vincent Merens¹, Ayla Smout¹

¹Liver Cell Biology Research Group, Vrije Universiteit Brussel, 1090 Brussel, Belgium.

|July 11, 2025

概括

研究人员使用诱导多能干细胞 (iPSC) 开发了先进的肝脏器官. 在这些模型中,用9-cis-retinoic acid (9CRA) 治疗改善了肝细胞功能,并增强了纤维性反应.

科学领域:

生物医学工程生物医学工程
肝病学肝病学是一种肝病学.
干细胞生物学干细胞生物学

背景情况:

肝纤维化是一个重要的全球健康问题,需要更好的体外模型.
目前基于诱导多能干细胞 (iPSC) 的肝脏模型往往缺乏关键的体内功能.
三维 (3D) 有机体培养对于模拟体内微环境至关重要.

研究的目的:

开发和描述使用iPSC衍生的肝细胞 (iHepatocytes) 和肝星细胞 (iHSCs) 的先进的3D肝器官.
在肝纤维化模型中研究转录因子RXRA及其配体9-cis-retinoic acid (9CRA) 的作用.
提高基于iPSC的模型的可靠性,用于研究药物诱导的肝损伤和纤维化.

主要方法:

来自iPSC的肝细胞和肝星细胞有机体的发展.
这些器官与HepaRG和初级HSC器官的比较.
RNA测序分析以确定关键分子参与者.
用9-cis-retinoic acid (9CRA) 治疗以评估其对细胞功能和纤维性反应的影响.

主要成果:

RNA测序确定了RXRA作为肝细胞分化和HSC静止的潜在调节者.
9-cis-retinoic acid (9CRA) 治疗促进了iHepatocyte新陈代谢和iHSC静止.
在有机体模型中,9CRA放大了对TGF-β和乙氨基的纤维性反应.

结论:

RXRA及其配体9CRA在调节肝细胞功能和纤维化过程中发挥作用.
9CRA可以增强iPSC衍生的肝脏器官的纤维反应.
这些发现表明,9CRA可以改进基于iPSC的模型,用于研究肝纤维化和药物诱导的肝损伤.

关键词:

迪利迪利迪利是一个词.药物代谢药物代谢肝星细胞激活的方法肝细胞肝细胞肝细胞这就是 iPSC 的意义.肝脏纤维化肝脏纤维化

更多相关视频

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells

Published on: December 9, 2022

Establishment and Genetic Manipulation of Murine Hepatocyte Organoids

Establishment and Genetic Manipulation of Murine Hepatocyte Organoids

Published on: February 12, 2022

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...